Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Aveo expects to $86.3 million in IPO - The Associated Press |
![]() |
![]() |
Aveo expects to $86.3 million in IPOThe Associated PressInc. The company's lead product candidate is Tivozanib, which is now in last-stage development as a renal cell cancer treatment.Aveo jumps into IPO game with plans to raise $86M FierceBiotechAveo Pharmaceuticals Files To Sell Up To $86.3M In IPO Wall Street Journal all 88 news articles » ... read more |